ArticleThe Journal of international medical research2025
Impact of digoxin on sinus rhythm restoration after catheter ablation of persistent atrial fibrillation and drug-refractory atrial tachyarrhythmia recurrence: A cohort study.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveEarly rhythm control has demonstrated clinical benefits even among patients with persistent atrial fibrillation. However, some patients continue to experience recurrent atrial tachyarrhythmias despite undergoing catheter ablation and treatment with antiarrhythmic drugs. This study aimed to assess the efficacy of digoxin in restoring sinus rhythm among patients with recurrent atrial tachyarrhythmias after catheter ablation and ongoing medical therapy.MethodsBetween 1 January 2013 and 1 September 2023, a total of 194 patients underwent catheter ablation for persistent atrial fibrillation. Among these, 96 (49.5%) patients experienced recurrence of atrial tachyarrhythmia during follow-up after catheter ablation. Of these, 12 patients with sustained arrhythmias despite at least 1 month of treatment with antiarrhythmic drugs and rate-control medications were treated with digoxin. Patients who achieved sinus rhythm after digoxin administration were categorized as the digoxin-effective group, and those who did not were classified as the non-digoxin-effective group. Clinical characteristics, medications, and echocardiographic parameters were compared between the two groups.ResultsAmong the 12 patients analyzed (mean age: 66 ± 7 years; 3 males and 9 females), 7 (58.3%) achieved sinus rhythm after digoxin administration. Patients in the digoxin-effective group exhibited significantly smaller left atrial sizes than those in the non-digoxin-effective group (39.2 ± 3.3 mm vs. 46.8 ± 2.6 mm, p = 0.017). Most recurrences in the digoxin-effective group were atrial tachycardia episodes (5/7, 71.4%). The median duration from digoxin initiation to sinus rhythm restoration was 49 days (range: 21-210 days). No serious adverse effects occurred.ConclusionsDigoxin effectively restored sinus rhythm in selected patients experiencing recurrent atrial tachyarrhythmias after catheter ablation and ongoing medical therapy, particularly among those with smaller left atrial sizes. Further research is warranted to validate these findings and explore the underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.